Fulcrum Capital’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.02M | Sell |
4,031
-345
| -8% | -$80.4K | 0.21% | 50 |
|
|
2026
Q1 | $1.07M | Sell |
4,376
-197
| -4% | -$45.9K | 0.23% | 48 |
|
|
2025
Q4 | $946K | Hold |
4,573
| – | – | 0.19% | 49 |
|
|
2025
Q3 | $848K | Hold |
4,573
| – | – | 0.17% | 49 |
|
|
2025
Q2 | $699K | Sell |
4,573
-408
| -8% | -$62.7K | 0.15% | 54 |
|
|
2025
Q1 | $826K | Buy |
4,981
+1,029
| +26% | +$161K | 0.18% | 51 |
|
|
2024
Q4 | $572K | Buy |
3,952
+254
| +7% | +$39.4K | 0.12% | 57 |
|
|
2024
Q3 | $599K | Buy |
3,698
+96
| +3% | +$15.3K | 0.13% | 58 |
|
|
2024
Q2 | $526K | Hold |
3,602
| – | – | 0.12% | 60 |
|
|
2024
Q1 | $570K | Buy |
3,602
+129
| +4% | +$20.5K | 0.14% | 59 |
|
|
2023
Q4 | $544K | Buy |
+3,473
| New | +$533K | 0.14% | 59 |
|
|
2023
Q3 | – | Sell |
-3,450
| Closed | -$571K | – | 112 |
|
|
2023
Q2 | $571K | Sell |
3,450
-59
| -2% | -$9.52K | 0.15% | 60 |
|
|
2023
Q1 | $544K | Sell |
3,509
-100
| -3% | -$16.1K | 0.15% | 64 |
|
|
2022
Q4 | $638K | Buy |
3,609
+800
| +28% | +$138K | 0.18% | 61 |
|
|
2022
Q3 | $459K | Buy |
2,809
+30
| +1% | +$5.08K | 0.14% | 60 |
|
|
2022
Q2 | $493K | Sell |
2,779
-7
| -0.3% | -$1.25K | 0.16% | 53 |
|
|
2022
Q1 | $494K | Sell |
2,786
-160
| -5% | -$27.2K | 0.13% | 50 |
|
|
2021
Q4 | $504K | Sell |
2,946
-564
| -16% | -$92.3K | 0.11% | 61 |
|
|
2021
Q3 | $567K | Sell |
3,510
-280
| -7% | -$47.8K | 0.14% | 56 |
|
|
2021
Q2 | $624K | Sell |
3,790
-36,042
| -90% | -$5.97M | 0.16% | 50 |
|
|
2021
Q1 | $6.55M | Sell |
39,832
-550
| -1% | -$89K | 1.88% | 26 |
|
|
2020
Q4 | $6.36M | Buy |
40,382
+3,002
| +8% | +$443K | 1.9% | 27 |
|
|
2020
Q3 | $5.57M | Sell |
37,380
-2,911
| -7% | -$431K | 2.01% | 27 |
|
|
2020
Q2 | $5.67M | Sell |
40,291
-3,556
| -8% | -$518K | 2.15% | 27 |
|
|
2020
Q1 | $5.75M | Sell |
43,847
-1,211
| -3% | -$172K | 2.61% | 18 |
|
|
2019
Q4 | $6.57M | Buy |
45,058
+1,591
| +4% | +$216K | 2.04% | 24 |
|
|
2019
Q3 | $5.62M | Buy |
43,467
+1,514
| +4% | +$199K | 1.92% | 25 |
|
|
2019
Q2 | $5.84M | Sell |
41,953
-6,167
| -13% | -$854K | 2.14% | 22 |
|
|
2019
Q1 | $6.73M | Buy |
48,120
+2,185
| +5% | +$293K | 2.54% | 12 |
|
|
2018
Q4 | $5.93M | Sell |
45,935
-3,436
| -7% | -$479K | 2.67% | 13 |
|
|
2018
Q3 | $6.82M | Buy |
49,371
+1,726
| +4% | +$229K | 2.66% | 11 |
|
|
2018
Q2 | $5.78M | Sell |
47,645
-216
| -0.5% | -$26.9K | 2.76% | 14 |
|
|
2018
Q1 | $6.13M | Buy |
47,861
+1,249
| +3% | +$169K | 2% | 17 |
|
|
2017
Q4 | $6.51M | Buy |
+46,612
| New | +$6.49M | 2.11% | 14 |
|
Other funds holding JNJ
Fulcrum Capital's JNJ Position: Q2 2026 in Review
Fulcrum Capital reduced its Johnson & Johnson (JNJ) stake by 7.9% in Q2 2026, selling an estimated $80.4K and leaving 4,031 shares worth $1.02M. The position accounts for 0.21% of the portfolio, ranked #50.
Fulcrum Capital first reported a position in JNJ in Q4 2017 and has held it in 34 quarters since. The position peaked at $6.82M in Q3 2018. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.
- Fulcrum Capital held 4,031 shares of Johnson & Johnson worth $1.02M as of Q2 2026.
- Fulcrum Capital sold 345 Johnson & Johnson shares in Q2 2026, an estimated $80.4K.
- Johnson & Johnson made up 0.21% of Fulcrum Capital's portfolio in Q2 2026, its #50 holding.
- Fulcrum Capital first reported a position in Johnson & Johnson in Q4 2017 and has held it in 34 quarters since.
- Fulcrum Capital's Johnson & Johnson position peaked at $6.82M in Q3 2018.
- 4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.
Based on Fulcrum Capital's 13F filing for Q2 2026, filed 21 Jul 2026.